Document Detail


Effects of fasting blood glucose, diabetes treatment, blood pressure and anti-hypertension treatment on cardiovascular disease incidence: a 30-year follow-up study of 740 incident patients with Type 2 diabetes.
MedLine Citation:
PMID:  23278364     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: To analyse the effects of hyperglycaemia and blood pressure, diabetes and anti-hypertension treatment on total and various types of cardiovascular disease incidence in patients with Type 2 diabetes followed for 30 years.
METHODS: A total of 740 incident patients with Type 2 diabetes were registered at the Laxå Primary Health Care Centre, Sweden between 1972 and 2001. Information on systolic, diastolic, and mean arterial blood pressure, mean fasting blood glucose, type of diabetes and anti-hypertension treatment was obtained from the patient records, and information on cardiovascular disease, myocardial infarction and stroke events from National Registers.
RESULTS: During the follow-up period the cumulative incidence of cardiovascular disease increased significantly with male sex (HR 1.52, 95% CI 1.25-1.85), age (HR 1.05, 95% CI 1.04-1.07), year of diabetes onset (HR 1.03, 95% CI 1.01-1.05), BMI, (HR 1.04, 95% CI 1.02-1.07), mean arterial blood pressure (HR 1.04, 95% CI 1.02-1.05) and number of previous cardiovascular disease events (HR 1.15, 95% CI 1.10-1.21), and decreased significantly with sulfonylurea treatment (HR 0.64, 95% CI 0.49-0.84), insulin (HR 0.57, 95% CI 0.33-0.98) and calcium channel blocker treatment (HR, 0.69, 95% CI 0.48-0.99). Cumulative incidence of myocardial infarction increased significantly with male sex, age, BMI, mean arterial blood pressure, number of previous myocardial infarction events and diuretic treatment, and decreased with metformin treatment. Cumulative incidence of stroke increased with age, year of diabetes onset, mean arterial blood pressure, and previous number of stroke events.
CONCLUSIONS: Cumulative cardiovascular disease, myocardial infarction and incidence of stroke increased with number of previous events and presence of hypertension and decreased with pharmacological anti-diabetic treatment and, to a lesser extent, with anti-hypertension treatment.
Authors:
S P O Jansson; D K G Andersson; K Svärdsudd
Related Documents :
24895484 - Assessment of metabolic status in young japanese females using postprandial glucose and...
23199534 - Evaluation of existing and candidate measures of obesity for detection of insulin resis...
25039824 - Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal a...
22082204 - L-carnitine ameliorated fatty liver in high-calorie diet/stz-induced type 2 diabetic mi...
22253604 - An sirna screen in pancreatic beta cells reveals a role for gpr27 in insulin production.
15298514 - Clinical outcome of primary infrainguinal subintimal angioplasty in diabetic patients w...
Publication Detail:
Type:  Research Support, Non-U.S. Gov't; Retracted Publication; Retraction of Publication    
Journal Detail:
Title:  Diabetic medicine : a journal of the British Diabetic Association     Volume:  30     ISSN:  1464-5491     ISO Abbreviation:  Diabet. Med.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-21     Completed Date:  2013-08-08     Revised Date:  2014-07-24    
Medline Journal Info:
Nlm Unique ID:  8500858     Medline TA:  Diabet Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  349-57     Citation Subset:  IM    
Copyright Information:
© 2012 The Authors. Diabetic Medicine © 2012 Diabetes UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Aged
Antihypertensive Agents / therapeutic use*
Blood Glucose / metabolism
Blood Pressure / physiology
Diabetes Mellitus, Type 2 / blood,  complications,  drug therapy*
Diabetic Angiopathies / complications,  drug therapy*
Fasting / blood*
Female
Follow-Up Studies
Humans
Hyperglycemia / complications
Hypertension / complications,  drug therapy*
Hypoglycemic Agents / administration & dosage*
Male
Middle Aged
Myocardial Infarction / complications,  drug therapy
Stroke / complications,  drug therapy
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Blood Glucose; 0/Hypoglycemic Agents
Comments/Corrections
Retraction In:
Diabet Med. 2013 Jul;30(7):888   [PMID:  23951575 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Frequency of Coronary Angiography and Revascularization among Men and Women with Myocardial Infarcti...
Next Document:  Charismatic authority in modern healthcare: the case of the 'diabetes specialist podiatrist'